Evidence map›Paper›PMID 30259283›Full record

ArticleBreast cancer research and treatment2019

Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty.

Ken Resnicow, Minal R Patel, M Chandler Mcleod, Steven J Katz, Reshma Jagsi

Open access · greenAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cost Consciousness Among Dermatologists.Clinical, cosmetic and investigational dermatology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Implementing routine communication about costs of cancer treatment: perspectives of providers, patients, and caregivers.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ken ResnicowDepartment of Health Behavior and Health Education, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI, 48109, USA. kresnic@umich.edu.ORCID http://orcid.org/0000-0003-1416-9627
Minal R PatelDepartment of Health Behavior and Health Education, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI, 48109, USA.
M Chandler McleodDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Steven J KatzDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Reshma JagsiDepartment of Radiation Oncology, Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, USA.
University of Michigan · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
The Challenge of Individualizing Treatments for Patients with Breast CancerP01CA163233 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOFER, TIMOTHY P. · 2012 to 2016
$13.4M
CDC HHS 5NU58DP003862-04/DP003862NCCDPHP CDC HHS U58 DP003862NCCDPHP CDC HHS U58 DP003875NCI NIH HHS HHSN261201000034CNCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS HHSN261201000140CNCI NIH HHS HHSN261201300015CNCI NIH HHS P01 CA163233NCI NIH HHS P30 CA046592NCI NIH HHS PO1CA163233
6 · The paper itself

Abstract

purposeHigh costs of cancer care place considerable burden on patients and society. Despite increasing recognition that providers should play a role in reducing care costs, how physicians across cancer specialties differ in their cost-consciousness has not been reported. We examined cost-consciousness regarding breast cancer care among medical oncologists, surgeons, and radiation oncologists.

methodsWe identified 514 cancer surgeons, 504 medical oncologists, and 251 radiation oncologists by patient report through the iCanCare study. iCanCare identified newly diagnosed women with breast cancer through the Surveillance, Epidemiology, and End Results (SEER) registries of Georgia and Los Angeles. We queried providers on three dimensions of cost-consciousness: (1) perceived importance of cost saving for society, patients, practice, and payers; (2) awareness of patient out-of-pocket expenses; and (3) discussion of financial burden.

resultsWe received responses from 376 surgeons (73%), 304 medical oncologists (60%), and 169 radiation oncologists (67%). Overall levels of cost-consciousness were moderate, with scores ranging from 2.5 to 3.0 out of 5. After adjusting for covariates, surgeons had the lowest scores on all three cost-consciousness measures; medical oncologists had the highest scores. Pairwise contrasts showed surgeons had significantly lower scores than medical oncologists for all three measures and significantly lower scores than radiation oncologists for two of the three cost-consciousness variables: importance of cost saving and discussion of financial burden.

conclusionsHow cost-consciousness impacts medical decision-making across specialty and how policy, structural, and behavioral interventions might sensitize providers regarding cost-related matters merit further examination.

Indexed as

Health Care CostsOncologistsSurgeonsAdultAgedBreast NeoplasmsDecision MakingFemaleGeorgiaHealth ExpendituresHumansMaleMiddle AgedPractice Patterns, Physicians'Surveys and QuestionnairesCancer care costsCost-consciousnessFinancial toxicityMedical oncologistsRadiation oncologistsSurgeons

Identifiers

PMID30259283
PMCPMC8968296
OpenAlexW2893177372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.